The chemical name, Letrozole is given to Novartis discriminating third generation Aromatase Inhibitor (AI). It was originated to fight breast cancer by suppressing the aromatization. Normally, it is used as a hormonal therapy for treating the breast cancer in women who have had their menopause. Originally, Letrozole was sold under the trade name Femara, and it was patented on July 25, 1997.
At present, Letrozole-Femara is possibly the most effective product on the market for this purpose. In structure and action, Letrozole-Femara is similar to its predecessor Arimidex. It blocks up the hormone estrogen fabrication. Some types of breast cancer need estrogen, and it stops tumor growth by diminishing estrogen intensity. Generic letrozole pills are not yet available. In the world of muscle building, Letrozole-Femara is used to lessen or eradicate excess estrogen caused by making the use of aromatizing steroids.
Letrozole-Femara reduces estrogen levels by 98% while elating testosterone levels. This rising percentage allows athletes to make use of Letrozole-Femara during or after a steroid cycle to destroy the gynecomastia related breast tissue. In addition, it is also...